Literature DB >> 18538864

Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation.

Seema V Maru1, Karen A Holloway, Geraldine Flynn, Christine L Lancashire, A Jane Loughlin, David K Male, Ignacio A Romero.   

Abstract

The expression of chemokine receptors and chemokine production by adult human non-transformed astrocytes, grade III astrocytoma and grade IV glioblastoma tumour cell lines were determined. Here, we show an increased expression of CXCR3 and CXCR4, and a decreased expression of CXCR1 and CCR4 by glioma cells compared to adult human astrocytes. Glioma cells showed increased production of CXCL10, whereas production of other chemokines was decreased (CXCL8, CCL2, CCL5, and CCL22). CXCL10 induced an ERK1/2-dependent increase in [(3)H] thymidine uptake. These results suggest that expression of chemokine receptor/ligand pairs such as CXCR3/CXCL10 have an important role in the proliferation of glioma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538864     DOI: 10.1016/j.jneuroim.2008.04.029

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  47 in total

Review 1.  Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.

Authors:  Xiao-hong Yao; Ying Liu; Keqiang Chen; Wanghua Gong; Ming-yong Liu; Xiu-wu Bian; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2011-09-17       Impact factor: 4.932

2.  The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.

Authors:  Keiji Tanese; Elizabeth A Grimm; Suhendan Ekmekcioglu
Journal:  Int J Cancer       Date:  2011-10-23       Impact factor: 7.396

3.  Roles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity.

Authors:  Yanlin Yu; Glenn Merlino
Journal:  Am J Pathol       Date:  2010-02-25       Impact factor: 4.307

4.  Chemokine receptor CXCR3 promotes growth of glioma.

Authors:  Che Liu; Defang Luo; Brent A Reynolds; Geeta Meher; Alan R Katritzky; Bao Lu; Craig J Gerard; Cyrus P Bhadha; Jeffrey K Harrison
Journal:  Carcinogenesis       Date:  2010-11-03       Impact factor: 4.944

5.  CXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13.

Authors:  Nan Gao; Xiaowei Liu; Jiayin Wu; Juan Li; Chen Dong; Xinyi Wu; Xiao Xiao; Fu-Shin X Yu
Journal:  Angiogenesis       Date:  2017-06-16       Impact factor: 9.596

6.  Radiofrequency ablation-increased CXCL10 is associated with earlier recurrence of hepatocellular carcinoma by promoting stemness.

Authors:  Yabo Ouyang; Kai Liu; Meijun Hao; Rongling Zheng; Chunmiao Zhang; Yanning Wu; Xiaofeng Zhang; Ning Li; Jiasheng Zheng; Dexi Chen
Journal:  Tumour Biol       Date:  2015-10-13

Review 7.  Effective effectors: How T cells access and infiltrate the central nervous system.

Authors:  Kendra L Congdon; Luis A Sanchez-Perez; John H Sampson
Journal:  Pharmacol Ther       Date:  2018-12-14       Impact factor: 12.310

8.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

Review 9.  Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Authors:  Rajasekharan Somasundaram; Dorothee Herlyn
Journal:  Semin Cancer Biol       Date:  2008-11-13       Impact factor: 15.707

10.  Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old question.

Authors:  Richard E Kast
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.